|
gptkbp:instanceOf
|
Psychoactive Fungi
|
|
gptkbp:broadcastOn
|
gptkb:Class_A_(UK)
Schedule I (USA)
Illegal (many countries)
|
|
gptkbp:commonSpecies
|
gptkb:Psilocybe_cubensis
gptkb:Psilocybe_cyanescens
gptkb:Psilocybe_semilanceata
|
|
gptkbp:consumedIn
|
gptkb:café
Edibles
Dried Mushrooms
|
|
gptkbp:contains
|
gptkb:Psilocybin
gptkb:Psilocin
|
|
gptkbp:culturalSignificance
|
Mesoamerican Shamanism
Modern Psychedelic Culture
|
|
gptkbp:discoveredBy
|
gptkb:Indigenous_Peoples
|
|
gptkbp:durationOfEffects
|
4-6 hours
|
|
gptkbp:effect
|
gptkb:Euphoria
gptkb:Hallucinations
Altered Perception
Spiritual Experiences
|
|
gptkbp:firstDescribed
|
20th Century
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Magic Mushrooms
|
|
gptkbp:intendedUse
|
Oral Ingestion
|
|
gptkbp:legalIn
|
gptkb:Australia
gptkb:Brazil
gptkb:Canada
gptkb:Jamaica
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:legalStatus
|
Varies by Country
|
|
gptkbp:mainActiveCompound
|
gptkb:Psilocybin
|
|
gptkbp:mechanismOfAction
|
Serotonin Receptor Agonist
|
|
gptkbp:notableEvent
|
gptkb:Harvard_Psilocybin_Project
1960s Psychedelic Movement
|
|
gptkbp:potentialTherapeuticUse
|
gptkb:Anxiety
PTSD
Depression
Addiction
|
|
gptkbp:relatedTo
|
Aeruginascin
Baeocystin
Norbaeocystin
|
|
gptkbp:researchStatus
|
Ongoing Clinical Trials
|
|
gptkbp:riskFactor
|
gptkb:Nausea
gptkb:Anxiety
gptkb:Bad_Trip
gptkb:Paranoia
Poisoning (if misidentified)
Misidentification with toxic species
|
|
gptkbp:studiedBy
|
gptkb:R._Gordon_Wasson
gptkb:Albert_Hofmann
gptkb:Terence_McKenna
|
|
gptkbp:toxicity
|
Low (when correctly identified)
|
|
gptkbp:usedFor
|
Recreational Drug
Spiritual Rituals
|
|
gptkbp:bfsParent
|
gptkb:Acornsoft_software
|
|
gptkbp:bfsLayer
|
7
|